Abstract
In an open multicenter trial 46 schizophrenic patients were treated with fluperlapine for 20 days. A mean daily dosage of 300-400 mg appeared to be an effective antipsychotic treatment in most cases. The marked antipsychotic effect was accompanied by a good improvement of depressive symptoms. Extrapyramidal side effects were extremely rare.
MeSH terms
-
Adult
-
Antipsychotic Agents / adverse effects
-
Antipsychotic Agents / therapeutic use*
-
Clinical Trials as Topic
-
Dibenzazepines / therapeutic use*
-
Dose-Response Relationship, Drug
-
Electroencephalography
-
Female
-
Humans
-
Male
-
Psychiatric Status Rating Scales
-
Psychotic Disorders / drug therapy*
-
Psychotic Disorders / psychology
-
Schizophrenia / drug therapy*
-
Schizophrenic Psychology
Substances
-
Antipsychotic Agents
-
Dibenzazepines
-
fluperlapine